355 related articles for article (PubMed ID: 21901480)
1. The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study.
Tai TY; Tsai KS; Tu ST; Wu JS; Chang CI; Chen CL; Shaw NS; Peng HY; Wang SY; Wu CH
Osteoporos Int; 2012 May; 23(5):1571-80. PubMed ID: 21901480
[TBL] [Abstract][Full Text] [Related]
2. Daidzein and genistein have differential effects in decreasing whole body bone mineral density but had no effect on hip and spine density in premenopausal women: A 2-year randomized, double-blind, placebo-controlled study.
Nayeem F; Chen NW; Nagamani M; Anderson KE; Lu LW
Nutr Res; 2019 Aug; 68():70-81. PubMed ID: 31421395
[TBL] [Abstract][Full Text] [Related]
3. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study.
Brink E; Coxam V; Robins S; Wahala K; Cassidy A; Branca F;
Am J Clin Nutr; 2008 Mar; 87(3):761-70. PubMed ID: 18326616
[TBL] [Abstract][Full Text] [Related]
4. The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis.
Zhu HM; Qin L; Garnero P; Genant HK; Zhang G; Dai K; Yao X; Gu G; Hao Y; Li Z; Zhao Y; Li W; Yang J; Zhao X; Shi D; Fuerst T; Lu Y; Li H; Zhang X; Li C; Zhao J; Wu Q; Zhao SJ
Osteoporos Int; 2012 Apr; 23(4):1317-27. PubMed ID: 21505910
[TBL] [Abstract][Full Text] [Related]
5. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial.
Levis S; Strickman-Stein N; Ganjei-Azar P; Xu P; Doerge DR; Krischer J
Arch Intern Med; 2011 Aug; 171(15):1363-9. PubMed ID: 21824950
[TBL] [Abstract][Full Text] [Related]
6. Antiosteoporotic Activity of Genistein Aglycone in Postmenopausal Women: Evidence from a Post-Hoc Analysis of a Multicenter Randomized Controlled Trial.
Arcoraci V; Atteritano M; Squadrito F; D'Anna R; Marini H; Santoro D; Minutoli L; Messina S; Altavilla D; Bitto A
Nutrients; 2017 Feb; 9(2):. PubMed ID: 28241420
[TBL] [Abstract][Full Text] [Related]
7. Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.
Lydeking-Olsen E; Beck-Jensen JE; Setchell KD; Holm-Jensen T
Eur J Nutr; 2004 Aug; 43(4):246-57. PubMed ID: 15309425
[TBL] [Abstract][Full Text] [Related]
8. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
[TBL] [Abstract][Full Text] [Related]
9. Soy isoflavones attenuate bone loss in early postmenopausal Chinese women : a single-blind randomized, placebo-controlled trial.
Ye YB; Tang XY; Verbruggen MA; Su YX
Eur J Nutr; 2006 Sep; 45(6):327-34. PubMed ID: 16763748
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial.
Binkley N; Bone H; Gilligan JP; Krause DS
Osteoporos Int; 2014 Nov; 25(11):2649-56. PubMed ID: 25027109
[TBL] [Abstract][Full Text] [Related]
11. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
[TBL] [Abstract][Full Text] [Related]
12. Dose-response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis.
Nakamura T; Matsumoto T; Sugimoto T; Shiraki M
Osteoporos Int; 2012 Mar; 23(3):1131-40. PubMed ID: 21927920
[TBL] [Abstract][Full Text] [Related]
13. Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: a randomized controlled trial.
Lambert MNT; Thybo CB; Lykkeboe S; Rasmussen LM; Frette X; Christensen LP; Jeppesen PB
Am J Clin Nutr; 2017 Sep; 106(3):909-920. PubMed ID: 28768651
[No Abstract] [Full Text] [Related]
14. The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.
Alekel DL; Van Loan MD; Koehler KJ; Hanson LN; Stewart JW; Hanson KB; Kurzer MS; Peterson CT
Am J Clin Nutr; 2010 Jan; 91(1):218-30. PubMed ID: 19906801
[TBL] [Abstract][Full Text] [Related]
15. Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women.
Atteritano M; Mazzaferro S; Frisina A; Cannata ML; Bitto A; D'Anna R; Squadrito F; Macrì I; Frisina N; Buemi M
Osteoporos Int; 2009 Nov; 20(11):1947-54. PubMed ID: 19238303
[TBL] [Abstract][Full Text] [Related]
16. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
[TBL] [Abstract][Full Text] [Related]
17. Effect of soy isoflavone extract supplements on bone mineral density in menopausal women: meta-analysis of randomized controlled trials.
Taku K; Melby MK; Takebayashi J; Mizuno S; Ishimi Y; Omori T; Watanabe S
Asia Pac J Clin Nutr; 2010; 19(1):33-42. PubMed ID: 20199985
[TBL] [Abstract][Full Text] [Related]
18. The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study.
Herd RJ; Balena R; Blake GM; Ryan PJ; Fogelman I
Am J Med; 1997 Aug; 103(2):92-9. PubMed ID: 9274891
[TBL] [Abstract][Full Text] [Related]
19. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
Binkley N; Bolognese M; Sidorowicz-Bialynicka A; Vally T; Trout R; Miller C; Buben CE; Gilligan JP; Krause DS;
J Bone Miner Res; 2012 Aug; 27(8):1821-9. PubMed ID: 22437792
[TBL] [Abstract][Full Text] [Related]
20. Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study.
Marini H; Bitto A; Altavilla D; Burnett BP; Polito F; Di Stefano V; Minutoli L; Atteritano M; Levy RM; D'Anna R; Frisina N; Mazzaferro S; Cancellieri F; Cannata ML; Corrado F; Frisina A; Adamo V; Lubrano C; Sansotta C; Marini R; Adamo EB; Squadrito F
J Clin Endocrinol Metab; 2008 Dec; 93(12):4787-96. PubMed ID: 18796517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
